CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Millions	Total	Total Crown Equity	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2022	$ 2,287	$ 1,849	$ 600	$ 0	$ 3,141	$ (1,892)	$ 438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	122	102			102		20
Other comprehensive income	104	103				103	1
Dividends declared	(36)	(29)			(29)		(7)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	11	11		11
Common stock repurchased	(6)	(6)		(6)
Balance at end of period at Mar. 31, 2023	2,482	2,030	601	4	3,214	(1,789)	452
Balance at beginning of period at Dec. 31, 2022	2,287	1,849	600	0	3,141	(1,892)	438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	509
Other comprehensive income	142					144
Balance at end of period at Sep. 30, 2023	2,828	2,341	604	12	3,473	(1,748)	487
Balance at beginning of period at Mar. 31, 2023	2,482	2,030	601	4	3,214	(1,789)	452
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	187	157			157		30
Other comprehensive income	73	75				75	(2)
Dividends declared	(28)	(28)			(28)
Stock-based compensation	6	6		6
Common stock repurchased	(5)	(5)		(5)
Balance at end of period at Jun. 30, 2023	2,715	2,235	601	5	3,343	(1,714)	480
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	200	159			159		41
Other comprehensive income	(35)	(34)				(34)	(1)
Dividends declared	(62)	(29)			(29)		(33)
Restricted stock awarded	0	0	3	(3)
Stock-based compensation	10	10		10
Common stock issued	1	1		1
Common stock repurchased	(1)	(1)		(1)
Balance at end of period at Sep. 30, 2023	2,828	2,341	604	12	3,473	(1,748)	487
Balance at beginning of period at Dec. 31, 2023	2,864	2,410	604	17	3,476	(1,687)	454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	93	67			67		26
Other comprehensive income	13	16				16	(3)
Dividends declared	(45)	(30)			(30)		(15)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	12	12		12
Common stock repurchased	(5)	(5)		(5)
Balance at end of period at Mar. 31, 2024	2,932	2,470	605	23	3,513	(1,671)	462
Balance at beginning of period at Dec. 31, 2023	2,864	2,410	604	17	3,476	(1,687)	454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	168
Other comprehensive income	232					230
Common stock repurchased	(117)
Balance at end of period at Sep. 30, 2024	3,045	2,532	599	0	3,390	(1,457)	513
Balance at beginning of period at Mar. 31, 2024	2,932	2,470	605	23	3,513	(1,671)	462
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	207	174			174		33
Other comprehensive income	(114)	(114)				(114)
Dividends declared	(55)	(30)			(30)		(25)
Stock-based compensation	8	8		8
Common stock issued	1	1		1
Common stock repurchased	(2)	(2)		(2)
Balance at end of period at Jun. 30, 2024	2,977	2,507	605	30	3,657	(1,785)	470
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(132)	(175)			(175)		43
Other comprehensive income	333	328				328	5
Dividends declared	(35)	(30)			(30)		(5)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	12	12		12
Common stock repurchased	(110)	(110)	(7)	(41)	(62)
Balance at end of period at Sep. 30, 2024	$ 3,045	$ 2,532	$ 599	$ 0	$ 3,390	$ (1,457)	$ 513